Grant Verstandig, Director at NexImmune, Inc. (NEXI), bought 178,148 shares at $2.38 ($392K) on 2022-06-01, disclosed to the SEC on 2022-06-02.
Open-market purchase of $392k NEXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.11 | 45,024 | $95K | 24.2% |
| 2 | $2.11 | 45,024 | $95K | 24.2% |
| 3 | $2.38 | 40,200 | $96K | 24.4% |
| 4 | $2.23 | 47,900 | $107K | 27.2% |
| Total | $2.20 avg | 178,148 | $392K | 100% |
| Filing → |
| NEXI | BUY | 2021-02-19 | $3.0M | — | Filing → |